Physician's Desk Reference에 나타난 인종차이 분석
Analysis of Ethnic Differences in Physician's Desk Reference
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: The aim of study was to investigate the racial or ethnic differences in FDA-approved medications. Methods: Data on racial-based differences of drugs in PDR (Physician’s Desk Reference) were analyzed by searching with keywords, “ETHNIC”and “RACE”. Results: There were descriptions related to “ETHNIC” in product directions of 53 cases and “RACE” in 266 cases in 2010 PDR. After excluding 30 cases of duplicates, 289 cases were shown of which 28 cases were verified to demonstrate racial or ethnic differences. Drug category showing the higher racial or ethnic differences was cardiovascular drugs (7), followed by alimentary tract and metabolism drugs (6), nervous system drugs (5), and antineoplastic and immunomodulating agents (3). Pharmacokinetic differences between race and ethnicity were observed most frequently; differences in AUC or Cmax showed in 15 drugs and clearance differences in 7 drugs. Conclusions: This study identified the racial differences in medication usage in PDR. Therefore, the results can contribute to safe use of medication in real clinical settings in regards to the racial or ethnic differences.
Abstract
Purpose: The aim of study was to investigate the racial or ethnic differences in FDA-approved medications. Methods: Data on racial-based differences of drugs in PDR (Physician’s Desk Reference) were analyzed by searching with keywords, “ETHNIC”and “RACE”. Results: There were descriptions related to “ETHNIC” in product directions of 53 cases and “RACE” in 266 cases in 2010 PDR. After excluding 30 cases of duplicates, 289 cases were shown of which 28 cases were verified to demonstrate racial or ethnic differences. Drug category showing the higher racial or ethnic differences was cardiovascular drugs (7), followed by alimentary tract and metabolism drugs (6), nervous system drugs (5), and antineoplastic and immunomodulating agents (3). Pharmacokinetic differences between race and ethnicity were observed most frequently; differences in AUC or Cmax showed in 15 drugs and clearance differences in 7 drugs. Conclusions: This study identified the racial differences in medication usage in PDR. Therefore, the results can contribute to safe use of medication in real clinical settings in regards to the racial or ethnic differences.
참고문헌 (21)
- Yasuda SU, "The role of ethnicity in Variability in response to drugs: focus on clinical pharmacology studies", Clin Pharmacol Ther, 84(3), pp.417~423 (2008)
- McDowell SE, "Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine", BMJ, 332(7551), pp.1177~1182 (2006)
- Larisa H, "Pharmacogenetics, In Pharmacotherapy: a pathophysiologic approach", pp.55~59 (2002), Mc Graw Hill
- Miners JO, "Cytochrome P450 2C9: an enzyme of major importance in human drug metabolism", Br J Clin Pharmacol, 45(6), pp.525~538 (1998)
- Scott SA, "Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups", Pharmacogenomics, 11(6), pp.781~791 (2010)
- McDowell SE, "Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine", BMJ, 332(7551), pp.1177~1182 (2006)
- "가교자료평가 가이드라인", 식품의약품안전청, ~, 발간등록번호 11-1470000-001719-01
- Campbell D, "Pharmerging Shake-up: new imperatives in a re-defined world" (2010), IMS
- "PDR® Electronic Library on CD-ROM" (2010), LLC
- "Ethnic Factors In The Acceptability of Foreign Clinical Data E5(R1)" (1998)[URL]
- FDA, "Investigational new drug applications and new drug applications Final rule", Fed Regist, 63(28), pp.6854~6862 (1998)
- "Guidance for industry Collection of Race and Ethnicity Data in Clinical Trials" (2005)[URL]
- "Department of Health and Human Service"[URL]
- "Centers for Disease Control and Prevention"[URL]
- Prostate Cancer Screening: A Decision Guide for African Americans, , CDC, ~ (2003)
- Rotimi CN, "Ancestry and disease in the age of genomic medicine", N Engl J Med, 363(16), pp.1551~1558 (2010)
- "Asian & Pacic Islander American Health Forum"[URL]
- "The International Society on Hypertension in Blacks"[URL]
- Dugluas JG, "Management of high blood pressure in african americans", Arch Intern Med, 163(5), pp.525~541 (2003)
- Flack JM, "Management of high blood pressure in blacks; an update of the international society on hypertension in blacks consensus statement", Hypertension, 56, pp.780~800 (2010)
- Séguin B, "BiDil®: recontextualizing the race debate", Pharmacogenomics J, 8(3), pp.169~173 (2008)